1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with taurine in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (47.27) | 18.7374 |
1990's | 29 (52.73) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldvinsdóttir, J; Loftsson, T | 1 |
Aapro, M; Demierre, B; Gregor, A; Ironside, JW; Malmström, P; Rampling, R; Rye, R; Sellar, R; Stewart, M; Whittle, IR | 1 |
Hartley-Asp, B | 1 |
Bibby, MC; Cox, JA; Crawford, SM; Quinn, PK | 1 |
al-Ghabban, AF; Bibby, MC; Double, JA; Loadman, PM | 1 |
Glover, DJ | 1 |
Mason, C; Padwick, DJ; Panoutsopoulos, GI; Pearson, D; Smith, JA | 1 |
Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB; Vibe-Petersen, J | 2 |
Franklin, HR; McVie, JG; Taal, BG; ten Bokkel Huinink, WW | 1 |
MacPherson, JS; Miller, JD; Smyth, JF; Whittle, IR | 1 |
Drings, P; Edler, L; Fiebig, HH; Gatzemeier, U; Hinke, A; Rieche, K; Tessen, HW | 1 |
Grönquist, L; Gunnarsson, PO; Seidegård, J | 1 |
Brandin, S; Gustafsson, B; Ottersgård-Brorsson, A; Polacek, J | 1 |
Bach, F; Hansen, HH; Pedersen, AG; Smyth, J; Vibe-Petersen, J | 1 |
Atassi, G; Dumont, P; Fournier, JP; Gosse, C; Gouyette, A; Roger, P | 1 |
Bono, AV; De Pauw, M; Droz, JP; Fossa, ST; Keizer, J; Splinter, TA; Sylvester, R; Van Oosterom, AT; Verbaeys, AJ | 1 |
Pratesi, G; Savi, G | 1 |
Bergh, J; Blomquist, E; Gjedde, SB; Lindegaard-Madsen, E; Mouridsen, HT; Nolte, H | 1 |
Gundersen, S; Pinedo, HM; Renard, J; Smyth, JF | 1 |
Hartley-Asp, B; Kruse, E | 1 |
Bruntsch, U; Cavalli, F; Dombernowsky, P; Gundersen, S; Pinedo, H; Renard, J; Van Glabbeke, M | 1 |
Dexter, TM; Jelinek, J; Kleibl, K; Margison, GP | 1 |
Ellman, M; Gunnarsson, PO; Hansen, HH; Macpherson, JS; Polacek, J; Smyth, JF; Vibe-Petersen, J; Warrington, PS | 1 |
Dean, SW; Gibson, NW; Tew, KD | 1 |
Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindeløv, LL | 1 |
Bibby, MC; Bloomer, JC; Double, JA; Loadman, PM | 1 |
Bibby, MC; Double, JA; Morris, CM | 1 |
Bibby, MC; Double, JA; Phillips, RM | 1 |
Clavel, M; Dombernowsky, P; Howell, A; Pinedo, HM; Renard, J; Smyth, JF; van Glabekke, M | 1 |
Hansen, M; Heaf, JG | 1 |
Macpherson, JS; Miller, JD; Smyth, J; Whittle, IR | 1 |
Workman, P | 1 |
Brandin, S; Gunnarsson, PO; Polacek, J | 1 |
Anderson, LE; Fergusson, RJ; Macpherson, JS; Robins, P; Smyth, JF | 1 |
Christensson, PI; Gunnarsson, K; Gunnarsson, PO; Hartley-Asp, B; Jensen, G; Polacek, J; Stamvik, A | 1 |
Bork, E; Hansen, HH; Møller, H; Vibe-Petersen, J | 1 |
Cornbleet, MA; Kerr, ME; Leonard, RC; Macpherson, JS; Smyth, JF; Warrington, PS; Whelan, JM | 1 |
Molineux, G; Schofield, R; Testa, NG | 1 |
Balslev, I; Ernst, P; Mouridsen, HT | 1 |
d'Argy, R; Gunnarsson, PO; Johansson, CJ; Lundin, N; Teder, H | 1 |
Boot, H; Gortzak, E; Taal, BG; Van den Hout, BM; Zoetmulder, FA | 1 |
Bergh, J; Blomquist, E; Gjedde, SB; Jensen, NV; L-Madsen, E; Mouridsen, HT; Söderberg, M; Wählby, S | 2 |
Bibby, MC; Hill, SR | 1 |
Belal, F; Hefnawy, MM; Metwally, ME; Walash, MI | 1 |
Rodenhuis, S; Taal, BG; Ten Bokkel Huinink, WW | 2 |
Bibby, MC; Loadman, PM; Matthew, AM; Phillips, RM | 1 |
Chaudry, IH; Graffner, HO; Milsom, JW; Singh, G | 1 |
Gunnarsson, PO; Seidegård, J; Tuvesson, H | 2 |
Alderson, D; Denton, G; Grace, RH; Hardcastle, JD; Lauri, H; Mansi, JL; Nordle, O; Smyth, JF; Wählby, S; Yosef, HM | 1 |
Ellman, M; Gunnarsson, PO; Hansen, HH; Hansson, K; Hartley-Asp, B; Polacek, J; Vibe-Petersen, J | 1 |
Wils, J | 1 |
1 review(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and taurine
Article | Year |
---|---|
TCNU: a ray of hope for designer nitrosoureas?
Topics: Antineoplastic Agents; Humans; Neoplasms; Nitrosourea Compounds; Taurine | 1987 |
7 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and taurine
Article | Year |
---|---|
Phase II study of tauromustine in malignant glioma.
Topics: Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Nausea; Nitrosourea Compounds; Prospective Studies; Taurine; Thrombocytopenia | 1992 |
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Follow-Up Studies; Germany, West; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Survival Rate; Taurine | 1990 |
Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Nitrosourea Compounds; Random Allocation; Taurine | 1989 |
Phase II study of tauromustine in disseminated malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Taurine; Treatment Outcome | 1994 |
Phase I study of tauromustine administered in a weekly schedule.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Taurine; Thrombocytopenia | 1993 |
Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Taurine | 1993 |
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Quality of Life; Regression Analysis; Survival Rate; Taurine; Treatment Failure | 1995 |
47 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and taurine
Article | Year |
---|---|
Degradation of tauromustine (TCNU) in aqueous solutions.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Drug Stability; Nitrosourea Compounds; Solutions; Taurine; Water | 1992 |
Genotoxicity of tauromustine, a new water soluble taurine-based nitrosourea. I. Mutagenic and clastogenic activity of tauromustine in vitro.
Topics: Antineoplastic Agents; Cell Cycle; Chromosome Aberrations; Humans; In Vitro Techniques; Lomustine; Lymphocytes; Mutagenicity Tests; Mutagens; Nitrosourea Compounds; Salmonella typhimurium; Sister Chromatid Exchange; Taurine | 1992 |
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cell Division; Cell Line; Colonic Neoplasms; Hydralazine; Male; Melphalan; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Radionuclide Imaging; Regional Blood Flow; Taurine; Tumor Stem Cell Assay | 1992 |
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Synergism; Glomerular Filtration Rate; Half-Life; Hydralazine; Injections, Intravenous; Insulin; Kidney; Liver; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Taurine; Tissue Distribution | 1992 |
New approaches to the chemotherapy of melanoma.
Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine | 1991 |
Effects of melatonin on the release and production of blood leukocytes after administration of a novel taurine-based nitrosourea cytotoxic agent.
Topics: Animals; Antineoplastic Agents; Cell Division; Circadian Rhythm; Female; Guinea Pigs; Leukocyte Count; Leukocytes; Male; Melatonin; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Taurine | 1991 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Taurine; Vindesine | 1990 |
5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1990 |
The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Intracranial Pressure; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1990 |
TCNU in adenocarcinoma of the lung: a phase II study with divided doses.
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Nitrosourea Compounds; Taurine | 1990 |
Metabolism of a novel nitrosourea, tauromustine, in the rat.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; In Vitro Techniques; Male; Microsomes; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Taurine | 1990 |
Determination of tauromustine and its demethylated metabolites in plasma and urine.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Nitrosourea Compounds; Taurine | 1990 |
A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Nitrosourea Compounds; Taurine; Time Factors | 1989 |
TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Effects of tauromustine, a water-soluble nitrosourea compound on NMU-1 murine lung tumor.
Topics: Animals; Carmustine; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1989 |
Phase II study of tauromustine in disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Humans; Melanoma; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
The effect of estramustine, nor-nitrogen mustard and tauromustine on macromolecular labelling in the human prostatic tumour cell line 1013L.
Topics: Affinity Labels; Biological Transport; Cell Survival; DNA, Neoplasm; Estramustine; Humans; Leucine; Macromolecular Substances; Male; Nitrogen Mustard Compounds; Nitrosourea Compounds; Nucleotides; Prostatic Neoplasms; RNA, Neoplasm; Taurine; Tumor Cells, Cultured | 1989 |
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents.
Topics: Alkyl and Aryl Transferases; Alkylating Agents; Animals; Deoxyribonuclease BamHI; Deoxyribonuclease EcoRI; DNA Restriction Enzymes; Drug Resistance; Escherichia coli; Fluorometry; Hematopoietic Stem Cells; Mechlorethamine; Methyl Methanesulfonate; Methylnitrosourea; Mice; Nitrogen Mustard Compounds; Nitrosourea Compounds; Plasmids; Taurine; Transfection; Transferases | 1988 |
Pharmacokinetics of tauromustine in cancer patients. Phase I studies.
Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Neoplasms; Nitrosourea Compounds; Taurine | 1989 |
The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines.
Topics: Animals; Cell Line; Cell Survival; DNA, Neoplasm; Glutathione Reductase; Humans; Lomustine; Lung Neoplasms; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Rats; Streptozocin; Taurine | 1987 |
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
Topics: Carcinoma, Small Cell; Carmustine; Cell Cycle; Cell Line; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Lung Neoplasms; Nitrosourea Compounds; Taurine; Tumor Stem Cell Assay | 1987 |
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Colonic Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Neoplasm Transplantation; Nitrosourea Compounds; Taurine; Tissue Distribution | 1988 |
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Neoplasm Transplantation; Nitrosourea Compounds; Taurine | 1988 |
In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Mice; Neoplasm Transplantation; Nitrosourea Compounds; Taurine; Tumor Cells, Cultured | 1988 |
Phase II study of TCNU in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Nitrosourea Compounds; Taurine | 1988 |
Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
Topics: Adenocarcinoma; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Lung Neoplasms; Middle Aged; Nitrosourea Compounds; Pamidronate; Taurine | 1988 |
Experimental cerebral and plasma pharmacokinetic studies of TCNU: implications for brain tumour chemotherapy.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Glioma; Male; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Taurine | 1987 |
Determination of tauromustine, a nitrosourea-based antitumour agent, in plasma by high-performance liquid chromatography.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dogs; Humans; Hydrogen-Ion Concentration; Nitrosourea Compounds; Taurine | 1988 |
Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.
Topics: Animals; Antineoplastic Agents; Bronchial Neoplasms; DNA Ligases; Humans; Lung; Male; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitrosourea Compounds; Taurine | 1988 |
Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).
Topics: Animals; Antineoplastic Agents; Biotransformation; Blood Cell Count; Chromatography, High Pressure Liquid; Dogs; Female; Male; Mice; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Taurine; Tumor Cells, Cultured | 1988 |
A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Hematologic Diseases; Humans; Middle Aged; Neoplasms; Nitrosourea Compounds; Prohibitins; Taurine | 1987 |
Phase I study of TCNU, a novel nitrosourea.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Taurine; Vomiting | 1987 |
Hematopoietic effects of TCNU in mice.
Topics: Animals; Antineoplastic Agents; Female; Hematopoietic System; Lethal Dose 50; Male; Mice; Nitrosourea Compounds; Stem Cells; Taurine; Tumor Stem Cell Assay | 1987 |
Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Taurine | 1987 |
The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carbon Radioisotopes; Colonic Neoplasms; Injections, Intra-Arterial; Injections, Intravenous; Male; Microspheres; Neoplasm Transplantation; Nitrosourea Compounds; Rats; Rats, Wistar; Taurine; Time Factors; Tissue Distribution | 1995 |
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1995 |
5-Fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Fluorouracil; Male; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Protein Binding; Taurine | 1994 |
Fluorimetric determination of tauromustine (a novel antitumour agent) in formulations and biological fluids.
Topics: Antineoplastic Agents; Calibration; Chemistry, Pharmaceutical; Humans; Hydrogen-Ion Concentration; Nitrosourea Compounds; Regression Analysis; Sensitivity and Specificity; Spectrometry, Fluorescence; Tablets; Taurine | 1993 |
Tauromustine (TCNU) combined with 5-fluorouracil and leucovorin in the treatment of advanced colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nitrosourea Compounds; Taurine; Treatment Outcome | 1993 |
Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Drug Screening Assays, Antitumor; In Vitro Techniques; Mesylates; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Streptozocin; Taurine; Tumor Cells, Cultured | 1993 |
Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Leucovorin; Male; Mice; Mice, Inbred BALB C; Nitrosourea Compounds; Taurine | 1993 |
Measurement and characterization of the denitrosation of tauromustine and related nitrosoureas by glutathione transferases in liver cytosol from various species.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cytosol; Dogs; Enzyme Induction; Female; Glutathione Transferase; Hydrogen-Ion Concentration; In Vitro Techniques; Liver; Male; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Phenobarbital; Rats; Rats, Sprague-Dawley; Taurine; Temperature | 1993 |
Chromosome aberrations and pharmacokinetics in patients receiving tauromustine as either a single or a repeated dose.
Topics: Antineoplastic Agents; Chromosome Aberrations; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lung Neoplasms; Nitrosourea Compounds; Taurine | 1996 |
TCNU in colorectal cancer. How many patients are needed to demonstrate that a drug doesn't work?
Topics: Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Nitrosourea Compounds; Survival Rate; Taurine; Treatment Failure | 1996 |
Metabolism of tauromustine in liver and lung microsomes from various species.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes; Dogs; Female; Humans; Lung; Male; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Nitrosourea Compounds; Oxidoreductases, N-Demethylating; Phenobarbital; Pregnenolone; Rats; Rats, Sprague-Dawley; Species Specificity; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Taurine; Testosterone | 1999 |